Date of first VCS test:  Tue Jan 7 12:44:06 2014 (EST)
Date of most recent VCS test:  Tue Jul 25 12:17:40 2017 (EDT)
Time site in operation:  1295 days

Tests with POSITIVE results (suggesting neurotoxin exposure is likely):  72.3%
Tests with NEGATIVE results (suggesting neurotoxin exposure is unlikely):  27.7%


Percentage of VCS test takers responding to at least 1 survey question:  78.8%

Percentage of VCS test takers self-rating their overall health on a scale of 1-10 (10 being highest/best):  78%
   Average self-rated overall health among all respondents:  5.77
   Average self-rated overall health among respondents with POSITIVE test results:  5.67
   Average self-rated overall health among respondents with NEGATIVE test results:  6.02

Percentage of VCS test takers who responded regarding recent mold exposure or suspected mold exposure:  77.4%
   Percentage reporting recent mold exposure or suspected mold exposure:  58.7%
      With POSITIVE test results:  73.8%
      With NEGATIVE test results:  26.2%
   Percentage reporting NO recent mold exposure or suspected mold exposure:  41.3%
      With POSITIVE test results:  70%
      With NEGATIVE test results:  30%

Percentage of VCS test takers who responded regarding mold illness diagnosis:  45.5%
   Percentage reporting mold illness diagnosis:  20.1%
      With POSITIVE test results:  72.3%
      With NEGATIVE test results:  27.7%
   Percentage reporting NO mold illness diagnosis:  79.9%
      With POSITIVE test results:  74.1%
      With NEGATIVE test results:  25.9%

Percentage of VCS test takers who responded regarding exposures to other neurotoxins:  76.7%
   Percentage reporting exposure to other neurotoxins:  37.8%
      With POSITIVE test results:  73.1%
      With NEGATIVE test results:  26.9%
   Percentage reporting NO exposure to other neurotoxins:  62.2%
      With POSITIVE test results:  71.7%
      With NEGATIVE test results:  28.3%

Percentage of VCS test takers who responded regarding diagnosis with exposure to other neurotoxins:  29.2%
   Percentage reporting diagnosis with exposure to other neurotoxins:  31.2%
      With POSITIVE test results:  71.8%
      With NEGATIVE test results:  28.2%
   Percentage reporting NO diagnosis with exposure to other neurotoxins:  68.8%
      With POSITIVE test results:  73.3%
      With NEGATIVE test results:  26.7%

Percentage of VCS test takers who responded regarding other conditions involving neurological function:  76.8%
   Percentage reporting suffering from a condition involving neurological function:  28.8%
      With POSITIVE test results:  72.6%
      With NEGATIVE test results:  27.4%
   Percentage reporting suffering from NO condition involving neurological function:  71.2%
      With POSITIVE test results:  72.1%
      With NEGATIVE test results:  27.9%